Cytek Biosciences Inc. (CTKB)
NASDAQ: CTKB
· Real-Time Price · USD
3.42
0.03 (0.88%)
At close: Sep 26, 2025, 10:58 AM
0.88% (1D)
| Bid | 3.42 |
| Market Cap | 435.11M |
| Revenue (ttm) | 196.03M |
| Net Income (ttm) | -6.4M |
| EPS (ttm) | -0.05 |
| PE Ratio (ttm) | -68.4 |
| Forward PE | -34.1 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 3.43 |
| Volume | 110,073 |
| Avg. Volume (20D) | 1,029,206 |
| Open | 3.39 |
| Previous Close | 3.39 |
| Day's Range | 3.38 - 3.47 |
| 52-Week Range | 2.37 - 7.63 |
| Beta | 1.36 |
| Ex-Dividend Date | n/a |
About CTKB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTKB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTKB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCytek Biosciences Inc. is scheduled to release its earnings on
Nov 4, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
-22.69%
Cytek Biosciences shares are trading lower after t...
Unlock content with
Pro Subscription
6 months ago
-6.65%
Cytek Biosciences shares are trading lower after the company reported worse-than-expected Q4 revenue results and issued FY25 revenue guidance below estimates.
